Seattle, WA · Founded 2021 · Privately Held (backing)
Developer of antibody-based therapeutics designed to enable targeted and regulated treatment of diseases. Bonum Therapeutics is based in Seattle, WA and was founded in 2021. Its last reported valuation was $130 million in Nov 2022. It has raised $127 million across 3 recorded rounds; the latest was a $26.9 million early-stage round in Apr 2026.
Last reported valuation
$130.0M
Oct 2026
Priced at
—
Total raised
$127.5M
Last round
Early Stage VC
Apr 2026
Team — not yet on record
No current team members for Bonum Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Bonum Therapeutics with a free account
·Watch Bonum Therapeutics: the Monday email on marks, rounds and moves
